VECT VectivBio

Watchlist

8.330

+0.210+2.59%

Trading Session 02/02 12:03 ET

High

8.360

Open

8.200

Turnover

25.44K

Low

8.150

Pre Close

8.120

Volume

3.08K

Intraday

Price Forecast

Comment

Announcement

VectivBio Files for Up to $350 Million Mixed-Securities Shelf
06:04 AM EST, 01/30/2023 (MT Newswires) -- VectivBio (VECT) on Friday filed a registration statement covering the potential sale of up to $350 million of securities from time to time. The filing cove
01-30 06:04 ET
Vectivbio Files $350M Mixed Securities Shelf
01-27 05:26 ET
VectivBio (NASDAQ:VECT) Vs. Enzon Pharmaceuticals (OTCMKTS:ENZN) Critical Review
Enzon Pharmaceuticals (OTCMKTS:ENZN – Get Rating) and VectivBio (NASDAQ:VECT – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on
01-15 02:41 ET
VectivBio Holding AG's (NASDAQ:VECT) Last Week's 15% Decline Must Have Disappointed Private Equity Firms Who Have a Significant Stake
A look at the shareholders of VectivBio Holding AG (NASDAQ:VECT) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are private equity firms with 38% owne
01-13 08:40 ET
Piper Recommends 'Down Market Cap' Biotech Exposure for 2023
12-20-2022 05:45:15 ET
VectivBio Holding AG (NASDAQ:VECT) Short Interest Down 26.5% in November
VectivBio Holding AG (NASDAQ:VECT – Get Rating) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 16,600 shares, a dec
12-16-2022 09:41:27 ET
VectivBio (NASDAQ:VECT) Earns Buy Rating From Analysts at Jefferies Financial Group
Equities researchers at Jefferies Financial Group started coverage on shares of VectivBio (NASDAQ:VECT – Get Rating) in a research note issued to investors on Tuesday, Briefing.com reports. The firm
12-13-2022 09:31:49 ET
Jefferies Starts VectivBio Holding at Buy With $18 Price Target
12-13-2022 07:40:38 ET
VectivBio Holding (VECT) Has a New Rating From Jefferies
12-13-2022 07:30:17 ET
VectivBio Holding Price Target Announced at $18.00/Share by Jefferies
12-13-2022 05:12:19 ET

Company Overview More

VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the development of treatments for severe rare conditions with significant unmet medical need. Its product pipeline include Apraglutide and CoMet. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland.

CEO： Dr. Luca Santarelli

Market： NASDAQ

Listing Date： 04/09/2021

Paper Trade More

Direction

Buy

Sell

Types

LMT Order

Price

QTY

Amount

Get Started

Hot List

TradeSearchNews

SymbolLatest price%Chg

Watchlist